EGFR and neoplasm: In our study, ECOG-PS ≥ 2, IV tumor stage, non-adenocarcinoma histology, EGFR wild-type status and NLR were predictors of worse OS, whilst tumor stage IV, wild-type EGFR status and NLR ≥ 3.7 were independent prognostic factors for worse PFS.